This Week in Sickle Cell News

Hello All!

This week's round up of developments in sickle cell  disease research and clinical care features exciting news from the NIH's Clinical Center in Bethesda, MD where half of the adults in a stem-cell transplant trial which reversed sickle cell disease, successfully stopped anti-rejection drugs. This trial was carried out by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute. This report in the Science Daily has more on the study.

This week's selection:

Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department

ß-Globin gene cluster haplotypes and clinical severity in sickle cell anemia patients in southern Brazil

Perioperative considerations in a sickle cell patient undergoing cardiopulmonary bypass

Assessment of Iron Status in Patient of Sickle Cell Disease and Trait and its Relationship with the Frequency of Blood Transfusion in Paediatric Patients Attending at B.S. Medical College & Hospital, Bankura, West Bengal, India 

Newborn screening for sickle cell disease–technical and legal aspects of a German pilot study with 38,220 participants 

Best Wishes!

The ASN Team